Literature DB >> 3084809

Induction of Epstein-Barr virus nuclear antigens.

D J Moss, T B Sculley, J H Pope.   

Abstract

Lymphocytes were infected with the QIMR-WIL strain of Epstein-Barr virus, and the induction of Epstein-Barr virus-associated nuclear antigens was determined by using the protein immunoblot. There was a temporal increase in six antigens, with Epstein-Barr nuclear antigen 2 being detected 1 day after infection. The appearance of these antigens was shown to be independent of cellular DNA synthesis.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3084809      PMCID： PMC253013     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  23 in total

1.  Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot.

Authors:  T B Sculley; D G Sculley; J H Pope
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

2.  Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro.

Authors:  D J Moss; J H Pope
Journal:  J Gen Virol       Date:  1972-11       Impact factor: 3.891

Review 3.  Calcium, cyclic adenosine 3',5'-monophosphate, and the control of cell proliferation: a review.

Authors:  J F Whitfield; R H Rixon; J P MacManus; S D Balk
Journal:  In Vitro       Date:  1973 Jan-Feb

4.  Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis.

Authors:  T Aya; T Osato
Journal:  Int J Cancer       Date:  1974-09-15       Impact factor: 7.396

5.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors:  J H Pope; M K Horne; W Scott
Journal:  Int J Cancer       Date:  1968-11-15       Impact factor: 7.396

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.

Authors:  J Menezes; M Jondal; W Leibold; G Dorval
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

9.  The control of human WI-38 cell proliferation by extracellular calcium and its elimination by SV-40 virus-induced proliferative transformation.

Authors:  A L Boynton; J F Whitfield; R J Isaacs; R Tremblay
Journal:  J Cell Physiol       Date:  1977-08       Impact factor: 6.384

10.  Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.

Authors:  W Henle; V Diehl; G Kohn; H Zur Hausen; G Henle
Journal:  Science       Date:  1967-09-01       Impact factor: 47.728
View more
  8 in total

Review 1.  Molecular basis for Epstein-Barr virus induced pathogenesis and disease.

Authors:  C Sample; E Kieff
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.

Authors:  C Schmidt; S R Burrows; T B Sculley; D J Moss; I S Misko
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.

Authors:  S F Tsang; F Wang; K M Izumi; E Kieff
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.

Authors:  C M Rooney; M Brimmell; M Buschle; G Allan; P J Farrell; J L Kolman
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

Authors:  S D Abbot; M Rowe; K Cadwallader; A Ricksten; J Gordon; F Wang; L Rymo; A B Rickinson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

7.  Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.

Authors:  C Rooney; J G Howe; S H Speck; G Miller
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

8.  Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.

Authors:  G Laux; F Dugrillon; C Eckert; B Adam; U Zimber-Strobl; G W Bornkamm
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.